Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The table below is a summary of the segment profit or loss, including significant segment expenses (in thousands):

	Year Ended December 31,
	2025		2024
Expenses
Clinical operations and development	$	47,630	$	27,146
Manufacturing and process development	48,798		23,411
Research and development personnel cost and other (including stock-based compensation)	25,544		10,330
Research	3,124		2,732
Total research and development	125,096		63,619
General and administrative personnel costs (including stock-based compensation)	20,582		12,545
Professional fees	5,910		3,696
Facility costs, IT, office expense and other	4,016		2,529
Total general and administrative expenses	30,508		18,770
Total operating expenses	155,604		82,389
Operating loss	(155,604)		(82,389)
Interest income	17,871		14,581
Total other income, net	17,871		14,581
Net income before losses	(137,733)		(67,808)
Income tax expense	(217)		(187)
Segment and consolidated net loss	$	(137,950)	$	(67,995)